| Prognostic value of 68Ga-DOTANOC PET/CT SUVmax in patients with neuroendocrine tumors of the pancreas V Ambrosini, D Campana, G Polverari, C Peterle, S Diodato, C Ricci, ... Journal of Nuclear Medicine 56 (12), 1843-1848, 2015 | 94 | 2015 |
| 11C-Choline PET/CT for restaging prostate cancer. Results from 4,426 scans in a single-centre patient series T Graziani, F Ceci, P Castellucci, G Polverari, GM Lima, F Lodi, ... European journal of nuclear medicine and molecular imaging 43, 1971-1979, 2016 | 91 | 2016 |
| 18F-FDG Pet Parameters and Radiomics Features Analysis in Advanced Nsclc Treated with Immunotherapy as Predictors of Therapy Response and Survival G Polverari, F Ceci, V Bertaglia, ML Reale, O Rampado, E Gallio, ... Cancers 12 (5), 1163, 2020 | 82 | 2020 |
| Prediction nomogram for 68Ga-PSMA-11 PET/CT in different clinical settings of PSA failure after radical treatment for prostate cancer F Ceci, L Bianchi, M Borghesi, G Polverari, A Farolfi, A Briganti, ... European journal of nuclear medicine and molecular imaging 47, 136-146, 2020 | 61 | 2020 |
| The role of 18F-FDG PET/CT in the detection of osteosarcoma recurrence A Angelini, F Ceci, P Castellucci, T Graziani, G Polverari, G Trovarelli, ... European journal of nuclear medicine and molecular imaging 44, 1712-1720, 2017 | 45 | 2017 |
| Artificial intelligence for reduced dose 18F-FDG PET examinations: a real-world deployment through a standardized framework and business case assessment K Katsari, D Penna, V Arena, G Polverari, A Ianniello, D Italiano, R Milani, ... EJNMMI physics 8, 1-15, 2021 | 44 | 2021 |
| 18F-fluorodeoxyglucose uptake in patient with asymptomatic severe acute respiratory syndrome coronavirus 2 (coronavirus disease 2019) referred to positron emission tomography … G Polverari, V Arena, F Ceci, E Pelosi, A Ianniello, E Poli, A Sandri, ... Journal of Thoracic Oncology 15 (6), 1078-1080, 2020 | 36 | 2020 |
| Predictive accuracy and clinical benefit of a nomogram aimed to predict 68Ga-PSMA PET/CT positivity in patients with prostate cancer recurrence and PSA < 1 … L Bianchi, M Borghesi, R Schiavina, P Castellucci, A Ercolino, FM Bianchi, ... European Journal of Nuclear Medicine and Molecular Imaging 47, 2100-2105, 2020 | 25 | 2020 |
| 18F-FDG uptake in Asymptomatic SARS-CoV-2 (COVID-19) patient, referred to PET/CT for Non-Small Cells Lung Cancer restaging G Polverari, V Arena, F Ceci, E Pelosi, A Ianniello, E Poli, A Sandri, ... J Thorac Oncol 15, 1078-80, 2020 | 25 | 2020 |
| Impact of segmentation and discretization on radiomic features in 68Ga-DOTA-TOC PET/CT images of neuroendocrine tumor V Liberini, B De Santi, O Rampado, E Gallio, B Dionisi, F Ceci, G Polverari, ... EJNMMI physics 8, 1-21, 2021 | 21 | 2021 |
| Male breast cancer detected by 68Ga-PSMA-11 PET/CT in a patient with prostate cancer with pelvic lymph node metastasis G Polverari, F Ceci, L Calderoni, V Cervati, A Farolfi, P Castellucci, S Fanti Clinical Genitourinary Cancer 17 (2), 154-156, 2019 | 11 | 2019 |
| Solitary mucinous prostate adenocarcinoma lung metastasis detected by 68Ga-PSMA-11 PET/CT G Polverari, F Ceci, M Allen-Auerbach, P Gupta, MC Fishbein, RE Reiter, ... Clinical genitourinary cancer 17 (1), e53-e55, 2019 | 10 | 2019 |
| 18F-FDG pet parameters and radiomics features analysis in advanced nsclc treated with immunotherapy as predictors of therapy response and survival. Cancers (Basel). 2020; 12: 5 G Polverari, F Ceci, V Bertaglia, ML Reale, O Rampado, E Gallio, ... DOI: https://doi. org/10.3390/cancers12051163, 0 | 9 | |
| [18F]FDG PET/CT for evaluating early response to neoadjuvant chemotherapy in pediatric patients with sarcoma: a prospective single-center trial G Polverari, F Ceci, R Passera, J Crane, L Du, G Li, S Fanti, N Bernthal, ... EJNMMI research 10, 1-12, 2020 | 8 | 2020 |
| Brain metabolic differences between pure bulbar and pure spinal ALS: a 2-[18F]FDG-PET study A Canosa, A Martino, A Giuliani, C Moglia, R Vasta, M Grassano, ... Journal of Neurology 270 (2), 953-959, 2023 | 5 | 2023 |
| Predictive value of baseline [18F] FDG PET/CT for response to systemic therapy in patients with advanced melanoma V Liberini, M Rubatto, R Mimmo, R Passera, F Ceci, P Fava, L Tonella, ... Journal of Clinical Medicine 10 (21), 4994, 2021 | 5 | 2021 |
| Clinical application of Fluciclovine PET, choline PET and gastrin-releasing polypeptide receptor (bombesin) targeting PET in prostate cancer F Ceci, P Castellucci, G Polverari, A Iagaru Current Opinion in Urology 30 (5), 641-648, 2020 | 5 | 2020 |
| A rare case of epididymal metastasis after radical prostatectomy detected by 68Ga-PSMA PET/CT G Polverari, F Ceci, T Graziani, C Cozzarini, P Castellucci, S Fanti Clinical Genitourinary Cancer 15 (3), e525-e527, 2017 | 5 | 2017 |
| 18F-FDG PET/CT imaging biomarkers for early and late evaluation of response to first-line chemotherapy in patients with pancreatic ductal adenocarcinoma MR Benz, WR Armstrong, F Ceci, G Polverari, TR Donahue, ZA Wainberg, ... Journal of Nuclear Medicine 63 (2), 199-204, 2022 | 4 | 2022 |
| Artificial intelligence for reduced dose 18F-FDG PET examinations: A real-world deployment through a standardized framework and business case assessment D Penna, K Katsari, V Arena, G Polverari, A Ianniello, D Italiano, R Milani, ... | 2 | 2020 |
Francesco CeciDirector of Nuclear Medicine Department - IEO European Institute of Oncology IRCCS, Milan, ItalyVerified email at ieo.it
